Article citationsMore>>
E. P. Winer, S. Tolaney, H. Nechushtan, R. Berger, R. Kurzrock, I. G. Ron, P. Schoffski, A. Awada, C. A. Yasenchak, H. A. Burris, D. A. Ramies, T. Rafferty and X. Shen, “Activity of Cabozantinib (XL184) in Metastatic Breast Cancer (MBC): Results from a Phase II Randomized Discontinuation Trial (RDT),” Journal of Clinical Oncology, Vol. 30, 2012, Abstract No. 535.
has been cited by the following article:
Related Articles:
-
Ezra Davar
-
Wei Li, Zhaojun Qian, Huiyu Li
-
Ablé Anoh Valentin, N’Guessan Boka Robert, Bamba El Hadji Sawaliho
-
Cyril Tarquinio, Juliette Machado, Raffaele Longo, Jérémie Siles, Julien Bruno, Sophie Gendarme, Amandine Ziegler, Naoual Mellouki, Elise Eby, Christine Rotonda
-
Ghada Ezzat Eladawei, Rasha Mohamed Abdellatif, Sheref Mohamed El-Taher